Anterior Cruciate Ligament Repair and Biologic Innovations

JBJS Rev. 2017 May;5(5):e2. doi: 10.2106/JBJS.RVW.16.00050.

Authors

Gregory R Waryasz¹, Stephen Marcaccio², Joseph A Gil¹, Brett D Owens¹, Paul D Fadale¹

Affiliations

¹ Department of Orthopaedic Surgery, Rhode Island Hospital/Brown University, Providence, Rhode Island.
² Warren Alpert Medical School of Brown University, Providence, Rhode Island.

PMID: 28486257
DOI: 10.2106/JBJS.RVW.16.00050

No abstract available

MeSH terms

Allografts
Anterior Cruciate Ligament / pathology
Anterior Cruciate Ligament / surgery*
Anterior Cruciate Ligament / transplantation*
Anterior Cruciate Ligament Injuries / surgery*
Autografts
Biological Products / therapeutic use*
Epidermal Growth Factor / therapeutic use
Humans
United States
United States Food and Drug Administration / organization & administration
Vascular Endothelial Growth Factor A / therapeutic use

Substances

Biological Products
Vascular Endothelial Growth Factor A
Epidermal Growth Factor